Telbivudine
SIGMA/SML0293 - ≥98% (HPLC)
Synonym: β-L-Thymidine; 1-(2-Deoxy-β-L-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-Pyrimidinedione; 2′-Deoxy-L-thymidine; Epavudine; L-Thymidine; NV 02B; Sebivo
CAS Number: 3424-98-4
Empirical Formula (Hill Notation): C10H14N2O5
Molecular Weight: 242.23
MDL Number: MFCD02683612
Linear Formula: C10H14N2O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C10H14N2O5/c1-5-3-12(1 |
| InChI key | IQFYYKKMVGJFEH-CSMHCCOUSA |
| optical activity | [α]/D -15 to -22°, c = 1 in H2O |
| Quality Level | 100 ![]() |
| SMILES string | CC1=CN([C@@H]2C[C@@H](O)[ |
| solubility | H2O: 10 mg/mL (clear solution) |
| storage temp. | 2-8°C |
| Application: | Telbivudine has been used to explore the mechanisms of telbivudine (LdT) induced creatine kinase (CK) elevation. |
| Biochem/physiol Actions: | Telbivudine is a nucleoside analog that is widely used to treat hepatitis B virus (HBV) infection. |
| Biochem/physiol Actions: | Telbivudine is a synthetic molecule containing β-L-configuration. Telbivudine improves the estimated glomerular filtration rate (eGFR) in response to chronic hepatitis B (CHB). It prevents perinatal transmission and enhances the hepatitis B e antigen (HBeAg) seroconversion. It is also known to cause side effects such as creatine kinase (CK) elevation and fatal rhabdomyolysis. |
| Biochem/physiol Actions: | Telbivudineis a Hepatitis B antiviral agent. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


